UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

Study of Montelukast for the Treatment of Respiratory Symptoms of Post-Respiratory Syncytial Virus Bronchiolitis in Children

American journal of respiratory and critical care medicine, 2008-10, Vol.178 (8), p.854-860

2008

Volltextzugriff (PDF)

A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma

Journal of allergy and clinical immunology, 2010-02, Vol.125 (2), p.374-380

2010

Volltextzugriff (PDF)

Intermittent or daily montelukast versus placebo for episodic asthma in children

Annals of allergy, asthma, & immunology, 2011-06, Vol.106 (6), p.518-526

2011

Volltextzugriff (PDF)

Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD

International journal of chronic obstructive pulmonary disease, 2012-01, Vol.7 (default), p.57-71

2012

Volltextzugriff (PDF)

MK-0633, a potent 5-lipoxygenase inhibitor, in chronic obstructive pulmonary disease

Respiratory medicine, 2011-03, Vol.105 (3), p.392-401

2011

Volltextzugriff (PDF)

The efficacy and tolerability of MK-0633, a 5-lipoxygenase inhibitor, in chronic asthma

Respiratory medicine, 2012-01, Vol.106 (1), p.34-46

2012

Volltextzugriff (PDF)

Airway obstruction lability helps distinguish levels of disease activity in asthma

Respiratory medicine, 2012-04, Vol.106 (4), p.500-507

2012

Volltextzugriff (PDF)

Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis

Annals of allergy, asthma, & immunology, 2005-12, Vol.95 (6), p.551-557

2005

Volltextzugriff (PDF)

Randomized, placebo-controlled study of a selective PDE4 inhibitor in the treatment of asthma

Respiratory medicine, 2009-03, Vol.103 (3), p.342-347

2009

Volltextzugriff (PDF)

Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study

Annals of allergy, asthma, & immunology, 2006-06, Vol.96 (6), p.800-807

2006

Volltextzugriff (PDF)

Onset and duration of attenuation of exercise-induced bronchoconstriction in children by single-dose of montelukast

Allergy and asthma proceedings, 2011-11, Vol.32 (6), p.453

2011

Volltextzugriff (PDF)

Response to montelukast among subgroups of children aged 2 to 14 years with asthma

Journal of allergy and clinical immunology, 2003-04, Vol.111 (4), p.757-762

2003

Volltextzugriff (PDF)

The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma

Clinical therapeutics, 2004-11, Vol.26 (11), p.1895-1904

2004

Volltextzugriff (PDF)

Validation of an asthma symptom diary for interventional studies

Archives of disease in childhood, 1999-05, Vol.80 (5), p.414-420

1999

Volltextzugriff (PDF)

Molecular Cloning and Functional Reconstitution of a Urate Transporter/Channel

The Journal of biological chemistry, 1997-01, Vol.272 (1), p.617-625

1997

Volltextzugriff (PDF)

MK-0633, a potent 5-lipoxygenase inhibitor, in chronic obstructive pulmonary disease: Focus on COPD

Respiratory medicine, 2011, Vol.105 (3), p.392-401

2011

Volltextzugriff (PDF)

Classical and channel-like urate transporters in rabbit renal brush border membranes

Kidney international, 1994-03, Vol.45 (3), p.727-736

1994

Volltextzugriff (PDF)

Isolation and immunolocalization of a rat renal cortical membrane urate transporter

The Journal of biological chemistry, 1994-03, Vol.269 (9), p.6759-6764

1994

Volltextzugriff (PDF)

Nucleofugal behavior of a β-shielded α-cyanovinyl carbanion

Beilstein journal of organic chemistry, 2018-12, Vol.14 (1), p.3018-3024

2018

Volltextzugriff (PDF)

Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled asthma: the SPIRIT randomised clinical trial

Respiratory research, 2021-12, Vol.22 (1), p.311-311, Article 311

2021

Volltextzugriff (PDF)

α-Deprotonation of a β-shielded acrylamide creates a distorted lithium 1-aminoallen-1-olate

Journal of organometallic chemistry, 2019-08, Vol.894, p.78-83

2019

Volltextzugriff (PDF)

Reports of suicidality in clinical trials of montelukast

Journal of allergy and clinical immunology, 2009-10, Vol.124 (4), p.691-696.e6

2009

Volltextzugriff (PDF)

β-Shielded Michael systems whose H–C(sp2) deprotonation and 1,2-addition reactions compete for organolithiums

Tetrahedron, 2018-12, Vol.74 (52), p.7466-7471

2018

Volltextzugriff (PDF)

Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials

The lancet respiratory medicine, 2021-01, Vol.9 (1), p.43-56

2021

Volltextzugriff (PDF)

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years

Pediatrics (Evanston), 2001-09, Vol.108 (3), p.E48

2001

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(74)

Publikationsform

Sprache

Englisch
(86)
Japanisch
(15)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Study of Montelukast for the Treatment of Respiratory Symptoms of Post-Respiratory Syncytial Virus Bronchiolitis in Children

A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma

Intermittent or daily montelukast versus placebo for episodic asthma in children

Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD

MK-0633, a potent 5-lipoxygenase inhibitor, in chronic obstructive pulmonary disease

The efficacy and tolerability of MK-0633, a 5-lipoxygenase inhibitor, in chronic asthma

Airway obstruction lability helps distinguish levels of disease activity in asthma

Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis

Randomized, placebo-controlled study of a selective PDE4 inhibitor in the treatment of asthma

Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study

Onset and duration of attenuation of exercise-induced bronchoconstriction in children by single-dose of montelukast

Response to montelukast among subgroups of children aged 2 to 14 years with asthma

The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma

Validation of an asthma symptom diary for interventional studies

Molecular Cloning and Functional Reconstitution of a Urate Transporter/Channel

MK-0633, a potent 5-lipoxygenase inhibitor, in chronic obstructive pulmonary disease: Focus on COPD

Classical and channel-like urate transporters in rabbit renal brush border membranes

Isolation and immunolocalization of a rat renal cortical membrane urate transporter

Nucleofugal behavior of a β-shielded α-cyanovinyl carbanion

Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled asthma: the SPIRIT randomised clinical trial

α-Deprotonation of a β-shielded acrylamide creates a distorted lithium 1-aminoallen-1-olate

Reports of suicidality in clinical trials of montelukast

β-Shielded Michael systems whose H–C(sp2) deprotonation and 1,2-addition reactions compete for organolithiums

Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years

Suchergebnisse filtern